<DOC>
	<DOCNO>NCT00762372</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety desflurane ( BLM-240 ) anesthetic agent demonstrate non-inferiority desflurane sevoflurane term awakening/recovery anesthesia .</brief_summary>
	<brief_title>Japan Phase 2/3 Clinical Study With BLM-240 ( Desflurane )</brief_title>
	<detailed_description>The study evaluate efficacy safety use desflurane ( BLM-240 ) ( without nitrous oxide ) maintenance general anesthesia adult patient undergoing surgical procedure typically perform general anesthesia Japan ( thoracic , abdominal , joint , back , neck ) , analgesic muscle relaxant concomitantly use . The study also intend demonstrate non-inferiority desflurane nitrous oxide sevoflurane nitrous oxide time awakening/recovery .</detailed_description>
	<mesh_term>Desflurane</mesh_term>
	<mesh_term>Isoflurane</mesh_term>
	<mesh_term>Nitrous Oxide</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>ASA PS 13 age : old 19 young 70 undergoing surgery thorax ( thoracotomy , thoracotomy plus laparotomy , endoscopy ; exclude cardiovascular ) , abdomen ( laparotomy , endoscopy ; exclude cesarean section ) , joint ( include peripheral vessel ) , back ( spine ) neck ( neck , throat ) willing hospitalize least 3 day 2 night ( day surgery day surgery ) give write consent need spinal subarachnoid , epidural local anesthesia ( except local surface infiltration anesthesia catheter insertion use local anesthetic test insert epidural catheter postsurgical pain ) contraindication use nitrous surgery anticipate need postoperative transfer intensive care unit receive mechanical pulmonary ventilation BMI 30 kg/m2 serious hepatic , renal , circulatory disorder ( Grade 3 per Notification 80 MHW , Pharmaceutical Affairs Bureau , Safety Division ) uncontrollable hypertension ( SBP 160 mmHg higher antihypertensive therapy ) emergency surgery history hypersensitivity component sevoflurane , fentanyl , propofol , vecuronium anesthetic contraindication sevoflurane , fentanyl , propofol , vecuronium exposure suspect exposure inhalational halogenated anesthetic within 3 mo prior consent know suspected history family history malignant hyperthermia consider likely difficulty receive tracheal intubation due condition brachygnathia , micrognathia , buck teeth , articular rheumatism injury cervical spine/cervical cord know suspected pregnant lactating participate clinical study within 6 mo prior consent history drug dependence history epilepsy otherwise judge investigator unsuitable study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>anesthesia</keyword>
	<keyword>desflurane</keyword>
</DOC>